Literature DB >> 9000481

Membrane tumor necrosis factor-alpha (TNF-alpha) expressed on HTLV-I-infected T cells mediates a costimulatory signal for B cell activation--characterization of membrane TNF-alpha.

M Higuchi1, K Nagasawa, T Horiuchi, M Oike, Y Ito, M Yasukawa, Y Niho.   

Abstract

The 26-kDa membrane tumor necrosis factor-alpha (TNF-alpha) expressed on activated CD4(+) T cells is a novel candidate for the functional membrane molecule in T-B cell interactions. We found that normal human T cells, when infected with human T cell lymphotropic virus type I (HTLV-I) in vitro, were induced to express the 26-kDa membrane TNF-alpha. The infected T cells, through this molecule, activated autologous B cells to produce immunoglobulin (Ig)M in a contact-dependent manner, which was partially inhibited by anti-TNF-alpha antibody (Ab). IgG synthesis was not stimulated, however, probably because of lack of CD40 ligand expression on the infected T cells. Anti-TNF-alpha Ab treatment stimulated the secretion of interleukin (IL)-2 and interferon gamma (IFN-gamma) in the infected T cells. These effects were not induced by anti-TNF receptor Ab treatment. Anti-TNF-alpha Ab also induced the elevation of intracellular calcium concentration in the infected T cells. These results suggest that T cells expressing membrane TNF-alpha can be directly stimulated through this molecule. Thus, it is suggested that the 26-kDa membrane TNF-alpha on HTLV-I-infected T cells plays a role in polyclonal B cell activation and may be involved in the pathogenesis of some HTLV-I-associated diseases. Additionally, our results suggest a novel mechanism by which cytokine production can be modulated in these T cells through membrane TNF-alpha on their surface.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9000481     DOI: 10.1006/clin.1996.4291

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  12 in total

1.  Reverse signalling of membrane-integrated tumour necrosis factor differentially regulates alloresponses of CD4+ and CD8+ T cells against human microvascular endothelial cells.

Authors:  Nalini K Vudattu; Ernst Holler; Patricia Ewing; Ute Schulz; Silvia Haffner; Verena Burger; Silvia Kirchner; Reinhard Andreesen; Günther Eissner
Journal:  Immunology       Date:  2005-08       Impact factor: 7.397

2.  A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in 'reverse signalling'.

Authors:  A D Watts; N H Hunt; Y Wanigasekara; G Bloomfield; D Wallach; B D Roufogalis; G Chaudhri
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

3.  The endogenous balance of soluble tumor necrosis factor receptors and tumor necrosis factor modulates cachexia and mortality in mice acutely infected with Trypanosoma cruzi.

Authors:  C Truyens; F Torrico; R Lucas; P De Baetselier; W A Buurman; Y Carlier
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

4.  Regulation of T-cell function by endogenously produced angiotensin II.

Authors:  Nyssa E Hoch; Tomasz J Guzik; Wei Chen; Tenecia Deans; Samer A Maalouf; Petra Gratze; Cornelia Weyand; David G Harrison
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-12-10       Impact factor: 3.619

Review 5.  Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents.

Authors:  Takahiko Horiuchi; Hiroki Mitoma; Shin-ichi Harashima; Hiroshi Tsukamoto; Terufumi Shimoda
Journal:  Rheumatology (Oxford)       Date:  2010-03-01       Impact factor: 7.580

6.  High circulating frequencies of tumor necrosis factor alpha- and interleukin-2-secreting human T-lymphotropic virus type 1 (HTLV-1)-specific CD4+ T cells in patients with HTLV-1-associated neurological disease.

Authors:  Peter K C Goon; Tadahiko Igakura; Emmanuel Hanon; Angelina J Mosley; Becca Asquith; Keith G Gould; Graham P Taylor; Jonathan N Weber; Charles R M Bangham
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

7.  T cell-derived tumour necrosis factor is essential, but not sufficient, for protection against Mycobacterium tuberculosis infection.

Authors:  B M Saunders; H Briscoe; W J Britton
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

Review 8.  Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer Immunotherapy.

Authors:  Cariad Chester; Katherine Fritsch; Holbrook E Kohrt
Journal:  Front Immunol       Date:  2015-12-02       Impact factor: 7.561

Review 9.  Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases.

Authors:  Ulrike Billmeier; Walburga Dieterich; Markus F Neurath; Raja Atreya
Journal:  World J Gastroenterol       Date:  2016-11-14       Impact factor: 5.742

Review 10.  TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease.

Authors:  Melissa K McCoy; Malú G Tansey
Journal:  J Neuroinflammation       Date:  2008-10-17       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.